Word

BELESALA

Status

Registered

Status Code

700

Status Date

Tuesday, October 27, 2020

Serial Number

79273317

Registration Number

6182097

Registration Date

Tuesday, October 27, 2020

Mark Type

4000

Filing Date

Tuesday, September 10, 2019

Published for Opposition

Tuesday, August 11, 2020

Trademark Owner History

Mallinckrodt Pharmaceuticals Ireland Limited - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; syringes sold prefilled with pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders, and intravenous analgesics and antipyretics

10 Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; medical device, namely, medical syringes used for manual injection

Trademark Events

Jan 21, 2024

New Representative At Ib Received

Apr 4, 2021

Final Decision Transaction Processed By Ib

Feb 11, 2021

Generic Madrid Transaction Sent To Ib

Feb 11, 2021

Generic Madrid Transaction Created

Jan 27, 2021

Final Disposition Notice Created, To Be Sent To Ib

Oct 27, 2020

Registered-Principal Register

Aug 11, 2020

Official Gazette Publication Confirmation E-Mailed

Aug 11, 2020

Published For Opposition

Aug 7, 2020

Notification Processed By Ib

Jul 22, 2020

Notification Of Possible Opposition Sent To Ib

Jul 22, 2020

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jul 22, 2020

Notification Of Notice Of Publication E-Mailed

Jul 7, 2020

Approved For Pub - Principal Register

Jul 7, 2020

Examiner's Amendment Entered

Jul 7, 2020

Notification Of Examiners Amendment E-Mailed

Jul 7, 2020

Examiners Amendment E-Mailed

Jul 7, 2020

Examiners Amendment -Written

Jul 6, 2020

Teas/Email Correspondence Entered

Jul 6, 2020

Correspondence Received In Law Office

Jul 6, 2020

Teas Response To Office Action Received

Feb 8, 2020

Refusal Processed By Ib

Jan 21, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Jan 21, 2020

Refusal Processed By Mpu

Dec 12, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Dec 11, 2019

Non-Final Action Written

Dec 11, 2019

Assigned To Examiner

Dec 10, 2019

Application Filing Receipt Mailed

Dec 6, 2019

New Application Office Supplied Data Entered

Dec 5, 2019

Sn Assigned For Sect 66a Appl From Ib